Related Experiment Video
Updated: Feb 11, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Interleukin-22: a potential immunomodulatory molecule in the lung
Hayley A Whittington1, Lynne Armstrong, Kay M Uppington
1Lung Research Group, Department of Clinical Sciences North Bristol, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
Interleukin-22 (IL-22) plays a role in regulating lung inflammation. Lower IL-22 levels were observed in patients with acute respiratory distress syndrome and sarcoidosis, suggesting its involvement in inflammatory lung diseases.
Area of Science:
- Immunology
- Pulmonary Medicine
- Molecular Biology
Background:
- Interleukin-22 (IL-22) is part of the type I interferon family, sharing characteristics with IL-10.
- IL-22 interacts with IL-10 receptor subunit 2 (IL-10R2c) and IL-22 receptor 1 (IL-22R1), with binding inhibited by IL-22 binding protein (IL-22BP).
- IL-22 and IL-22BP are hypothesized to be involved in inflammatory regulation and the pathogenesis of inflammatory lung diseases.
Purpose of the Study:
- To investigate the expression and function of IL-22 and IL-22BP in the context of pulmonary inflammation.
- To determine the role of IL-22 in inflammatory lung diseases such as acute respiratory distress syndrome (ARDS), sarcoidosis, and idiopathic pulmonary fibrosis (IPF).
Main Methods:
- Assessed mRNA expression of IL-22, IL-22BP, and IL-22R1 in various lung cells (alveolar macrophages, monocytes, alveolar epithelial cells, neutrophils).
- Utilized immunohistochemistry to confirm IL-22 protein expression in lung tissues.
- Quantified IL-22 levels in bronchoalveolar lavage fluid from patients with ARDS, sarcoidosis, IPF, and healthy controls using Western blotting.
- Evaluated the functional interaction of IL-22 and IL-10 on cytokine inhibition (TNF-alpha and IL-8) in relevant cell lines.
Main Results:
- IL-22 mRNA was detected in alveolar macrophages, monocytes, and alveolar epithelial cells.
- IL-22BP mRNA was found in alveolar macrophages, alveolar epithelial cells, and neutrophils, while IL-22R1 was exclusively expressed in alveolar epithelial cells.
- Lower IL-22 protein levels were found in bronchoalveolar lavage fluid of patients with ARDS and sarcoidosis compared to controls.
- IL-22 did not influence IL-10's inhibition of TNF-alpha in monocytes but showed synergistic IL-8 inhibition with IL-10 in IL-22R1-expressing A549 cells.
Conclusions:
- IL-22 is expressed in key pulmonary cells and its protein levels are altered in specific inflammatory lung conditions.
- The differential expression of IL-22 receptor components suggests cell-specific functions.
- IL-22, in conjunction with IL-10, can modulate inflammatory responses, particularly IL-8 production, in cells expressing IL-22R1, indicating a regulatory role in pulmonary inflammation.
Related Concept Videos
Molecules and Compounds
Lung Capacity
The Resting Membrane Potential
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Potential Energy
Standard Electrode Potentials

